Transfusion and Apheresis Science
Volume 45, Issue 3 , Pages 239-245 , December 2011

Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India

References 

  1. Jones HG, Bandarenko N. Management of the therapeutic apheresis patient. In:  McLeod B,  Price TH,  Weinstein R editor. Apheresis, principles and practice. Maryland: American Association of Blood Banks Press; 2003;p. 253–274
  2. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the apheresis applications committee of the american society for apheresis. J Clin Apher. 2010;25:83–177
  3. Rock GA, Herbert CA. Canadian apheresis group. Therapeutic apheresis in Canada. J Clin Apher. 1992;7:47–48
  4. Korach JM, Bussel A, Gajdos P. The national survey of plasma exchange and therapeutic cytapheresis in France. Transf Sci. 1995;16:363–370
  5. Malchesky PS, Skibinski CI. Summary of results of 1991 ASFA apheresis survey. J Clin Apher. 1993;8:96–101
  6. Shimizu M, Tsuda H, Sanaka T, Ide K. Present status of therapeutic apheresis in Japan: survey report. Ther Apher. 1998;2:172–181
  7. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nain RC, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991;325:393–397
  8. Srivastava R, Gupta RC, Khatri PC, Lalchandani A. Changing scenario of therapeutic apheresis in India in the last 14years. Ther Apher. 1998;2:317–319
  9. Gilcher RO. Apheresis: principles & practices. In:  Rossi EC,  Simon TL,  Moss GS,  Gould SA editor. Principles of transfusion medicine. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996;p. 537–545
  10. Srivastava R. Changing perspectives of apheresis in India in the twentieth century. Transfus Apher Sci. 2002;26:97–101
  11. Trikha I, Singh S, Goyal V, Shukla G, Bhasin R, Behari M. Comparative efficacy of low dose, daily versus alternate day plasma exchange in severe myasthenia gravis: a randomised trial. J Neurol. 2007;254:989–995
  12. Narciso CT. Apheresis in the Philippines. Transfus Apher Sci. 2005;33:3–9
  13. Moog R. Haemapheresis activities in Germany. Transfus Apher Sci. 2005;32:283–286
  14. Norda R, Stegmayr BG. The Swedish apheresis group. Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci. 2003;29:159–166
  15. Saltiel C. Apheresis activity in Venezuela. J Clin Apher. 2005;20:95–100
  16. Malchesky PS, Koo AP, Roberson GA, Hadsell AT, Rybicki LA. Apheresis technologies and clinical applications: the 2002 International Apheresis Registry. Ther Apher Dial. 2004;30:61–71
  17. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura – hemolytic uremic syndrome. Clinical experience in 108 patients. N Eng J Med. 1991;325(6):398–403
  18. Bandarenko N, Brecher ME. Members of the US TTP apheresis study group. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group: multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apheresis. 1998;13:133–141
  19. George JN. How I treat patients with thrombotic thrombocytopenic purpura – hemolytic uremic syndrome. Blood. 2000;96(4):1223–1229
  20. Weinstein R. Therapeutic apheresis in neurological disorders. L Clin Apher. 2000;15:74–128
  21. McLeod B. Therapeutic plasma exchange in neurological disorders. In:  McLeod BC,  Price TH,  Drew MJ editor. Apheresis: principles and practice. Bethesda, MD: AABB Press; 1997;p. 287–306
  22. Raphael JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain–Barre´ syndrome. Cochrane Database Syst Rev. 2002;2(2):CD001798
  23. George JN, Gilcher RO, Smith JW, Chandler L, Duvall D, Ellis C. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management. J Clin Apher. 1998;13:120–125
  24. Shemin D, Briggs D, Greenan M. Complications of therapeutic plasma exchange: a prospective study of 1727 procedures. J Clin Apher. 2007;22:270–276
  25. Lu Q, Nedelcu E, Ziman A, Bumerts P, Fernando L, Schilller G. Standardized protocol to identify high risk-patients undergoing therapeutic apheresis procedures. J Clin Apher. 2008;23:111–115
  26. Nguyen L, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009;49:392–394
  27. Remuzzi G, Noris M. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16:1035–1050
  28. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of shiga toxin- producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis. 2002;186:493–500
  29. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher. 2002;6:15–23
  30. Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O’Brien S, Anderlini P, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma. 2001;42:67–73
  31. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis. 1994;23:817–827
  32. Basic-Jukic N, Kes P, Glavasa-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial. 2005;9:391–395
  33. Lazo-Langner A, Espinosa-Poblano I, Tirado-Cárdenas N, Ramírez-Arvizu P, López-Salmorán J, Peñaloza-Ramírez P, et al. Therapeutic plasma exchange in Mexico: experience from a single institution. Am J Hematol. 2002;70:16–21
  34. Kaynar L, Altuntas F, Aydogdu I, Turgut B, Kocyigit I, Hacioglu SK, et al. Therapeutic plasma exchange in patients with neurologic disease: retrospective multicenter study. Transfus Apher Sci. 2008;38:109–115

PII: S1473-0502(11)00162-5

doi: 10.1016/j.transci.2011.09.002

Transfusion and Apheresis Science
Volume 45, Issue 3 , Pages 239-245 , December 2011

Article Tools